Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L
In recent years, GLP-1 receptor agonists have been explored for obesity treatment
In drawing on studies that extend from clinical epidemiology, through genetics, pharmacotherapy and animal models, to cell biology and biochemistry, we have aimed to provide a comprehensible and accessible narrative, although this comes at the expense of a fully comprehensive and systematic (and inevitably longer) analysis
Based on cross-trial data, CagriSema and tirzepatide produce nearly identical weight loss results, approximately 22 to 23% in non-diabetic populations with obesity
Evidence shows a crucial role of S100 proteins in the development and progress of inflammatory diseases, including psoriasis